Kyowa Pharmaceutical Inc.

Princeton, New Jersey 08540

0 studies enrolling now · 6 studies all time

What they study most

Movement Disorder Syndrome, Parkinson's Disease, Restless Legs Syndrome, Sleep Disorder

Studies at this site

• An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001 — Stopped early
• An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018 — Completed
• A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa — Completed
• A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa — Completed
• A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients — Completed
• Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome — Completed